Clinical Trials Directory

Trials / Completed

CompletedNCT05602402

To Evaluate the Efficacy and Safety of CAEP-01 on Eye Strain in Children With Heavy Screen Use

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Vedic Lifesciences Pvt. Ltd. · Industry
Sex
All
Age
10 Years – 14 Years
Healthy volunteers
Not accepted

Summary

Several recent clinical trials have highlighted the potential role of Product in promoting eye health.product whose structural and functional characteristics make it a promising bioactive compound in the prevention of several human diseases as well as in the maintenance of a good health status. it might relieve eyestrain in people using computer monitors as suggested who conducted a double-blind randomized clinical trial by enrolling visual display terminal workers and prescribed them product or placebo. Study outcomes were objectively evaluated by using a proper instrumentation to measure eye muscle endurance. Subjects receiving Product experienced a significant relief from eyestrain compared to the placebo group.

Conditions

Interventions

TypeNameDescription
OTHERCAEP-01Dose: 1 capsule Route: orally for 84 ± 3 days Regimen: one capsule before breakfast (preferably with milk/butter/ghee)
OTHERPlaceboDose: 1 capsule Route: orally for 84 ± 3 days Regimen: one capsule before breakfast (preferably with milk/butter/ghee)

Timeline

Start date
2022-11-11
Primary completion
2023-04-24
Completion
2023-04-24
First posted
2022-11-02
Last updated
2023-04-27

Locations

3 sites across 1 country: India

Source: ClinicalTrials.gov record NCT05602402. Inclusion in this directory is not an endorsement.